Artificial intelligence-enabled clinical phenotyping of human brown fat
Board or leadership role, 14 Oct 2026
Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study
Consulting or advice, Fees or honoraria, 7 Oct 2026
Gaps in lipid management among high-risk patients without prior MI or stroke: the VESALIUS-REAL global study
Consulting or advice, Fees or honoraria, Grants or research support, 3 Sept 2026
Effect on Lipoprotein(a) Oxidized Phospholipids of Lepodisiran, an Extended-Duration siRNA Targeting Lipoprotein(a)
Consulting or advice, 31 Aug 2026
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study
Fees or honoraria, 28 Aug 2026
Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study
Patents or royalties, Grants or research support, 28 Aug 2026
Low cardiovascular risk in early midlife and quality of life in old age: a life-long follow-up study in men
Consulting or advice, Fees or honoraria, 27 Aug 2026
Prediabetes: diagnostic aspects, clinical features, and emerging therapeutic opportunities, with a focus on Vitamin D
Consulting or advice, Fees or honoraria, Board or leadership role, 27 Aug 2026
Coronary Inflammation Is Associated With Plaque Progression in Men With HIV
Consulting or advice, Fees or honoraria, 26 Aug 2026
The impact and evolution of environmental/occupational, behavioural, and metabolic risk factors on CVD burdens in the Asia-Pacific region from 1990 to 2023: a secondary analysis of the Global Burden of Disease Study 2023
Consulting or advice, Fees or honoraria, 23 Aug 2026
Burden of cardiovascular diseases in the Asia-Pacific region from 1990 to 2023, with forecasts to 2050: a secondary analysis of the Global Burden of disease study 2023
Consulting or advice, Fees or honoraria, 21 Aug 2026
Incremental Predictive Value of Deep Learning-Quantified Coronary Atherosclerotic Volume: A SCAPIS Cohort Analysis
Fees or honoraria, 21 Aug 2026
Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network
Fees or honoraria, Board or leadership role, 19 Aug 2026
Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial
Consulting or advice, 18 Aug 2026
Digital recruitment and prevalence of screen-detected atrial fibrillation in nationwide patch-based ECG screening: the NORSCREEN randomized clinical trial
Consulting or advice, Fees or honoraria, 4 Aug 2026
Effectiveness, safety, and treatment persistence of bempedoic acid in a Spanish real-world cohort
Consulting or advice, Fees or honoraria, Board or leadership role, 31 Jul 2026
Real-world assessment of adherence to inclisiran dosing schedule and LDL-C reduction in patients with hypercholesterolemia in Austria
Consulting or advice, Fees or honoraria, Board or leadership role, 20 Jul 2026
Real-world efficacy of inclisiran: data from a tertiary lipid clinic
Consulting or advice, 1 Apr 2026
Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury
Consulting or advice, Grants or research support, 7 Mar 2024
Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults
Fees or honoraria, 16 Aug 2021